CD147 modulates autophagy through the PI3K/Akt/mTOR pathway in human prostate cancer PC-3 cells

Publisher： Spandidos Publications

E-ISSN： 1792-1082|9|3|1439-1443

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.3, 2015-01, pp. : 1439-1443

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway

By      

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 3085-3092

Spandidos Publications

Access to resources Recommend Favorite

Natural Products Targeting Autophagy via the PI3K/Akt/mTOR Pathway as Anticancer Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 7, 2013-09 ,pp. : 1048-1056

Bentham Science Publishers

Access to resources Recommend Favorite

Shikonin promotes autophagy in BXPC3 human pancreatic cancer cells through the PI3K/Akt signaling pathway

By    

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1087-1089

Spandidos Publications

Access to resources Recommend Favorite

Jolkinolide B induces apoptosis in MCF-7 cells through inhibition of the PI3K/Akt/mTOR signaling pathway

By          

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 212-218

Spandidos Publications

Access to resources Recommend Favorite

miR125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway

By          

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 681-686

Spandidos Publications

Access to resources Recommend Favorite